NR0B1 and type 2 diabetes mellitus: Another target for molecular detection in T2D patients could be represented by peroxisome proliferator-activated receptors (PPARs), which are fatty acid-activated transcription factors of nuclear hormone receptor superfamily that are well-established regulators of lipid metabolism, mitochondrial biogenesis, and energy homeostasis.